The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > ARCHIVE
ARCHIVE
- ACCJ White Paper Calls For Deregulations in Healthcare Services
August 20, 2001
- Bronchodilators Recommended for COPD: NBI Seminar
August 20, 2001
- Subcommittee Discusses Prices of Medical Materials
August 20, 2001
- Novo Nordisk: InnoLet, New Insulin Kit Targeted at the Elderly
August 20, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 20, 2001
- Fresenius to Supply Artificial Kidneys to Teijin
August 20, 2001
- Compounds under R&D by Japanese Makers in US Show Rapid Increases: JETRO Survey
August 20, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 20, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
August 6, 2001
- Kenporen to Cooperate with Nikkeiren, Rengo in Healthcare Reform
August 6, 2001
- CRO Business Expanding Rapidly: Association Report
August 6, 2001
- Chamber Councils Selection System to Be Started in Medical Malpractice Suits
August 6, 2001
- Kasamatsu Meiki, Hokuho Iyaku to Merge on Oct. 1
August 6, 2001
- WORLD NEW IN BRIEF
August 6, 2001
- Int'l Licensing Symposium to Be Held in Tokyo in September
August 6, 2001
- Gap between Boots and Mitsubishi Strategies Seen in Close of 4 Stores
August 6, 2001
- Development of Kissei's Rizaben Discontinued by GSK
August 6, 2001
- Sun Drug-Kawachi Yakuhin Alliance Likely to Be Successful: Security Analyst
August 6, 2001
- 3 Groups to Study How to Improve Supply of Drug Information
August 6, 2001
- BULLETIN
August 6, 2001
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…